Home
Abstract
My Abstract(s)
Login
ePosters
Back
Final Presentation Format
Eposter Presentation
Eposter in PDF Format
Accept format: PDF. The file size should not be more than 5MB
Eposter in Image Format
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
Presentation Date / Time
Submission Status
Withdrawn
Abstract
Abstract Title
Temporal trends of Male Primary Urethral Carcinoma: Potential Impact of Reduced Arsenic Exposure in Taiwan versus the USA
Presentation Type
Podium Abstract
Manuscript Type
Clinical Research
Abstract Category *
Oncology: Urethra/ Penis/ Testes/ Sarcoma/ Miscellaneous
Author's Information
Number of Authors (including submitting/presenting author) *
2
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Country
Taiwan
Co-author 1
Chen Wei-An cwa19971102@gmail.com National Cheng Kung University Hospital Department of Urology Tainan Taiwan *
Co-author 2
Tsai Yuh-Shyan youh@mail.nclu.edu.tw National Cheng Kung University Hospital Department of Urology Tainan Taiwan -
Co-author 3
-
Co-author 4
-
Co-author 5
-
Co-author 6
-
Co-author 7
-
Co-author 8
-
Co-author 9
-
Co-author 10
-
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
Co-author 16
Co-author 17
Co-author 18
Co-author 19
Co-author 20
Abstract Content
Introduction
Primary urethral cancer (PUC) is a rare urological malignancy. Prior research linked a higher prevalence of bulbomembranous adenocarcinoma in Taiwan to historical chronic arsenic exposure in drinking water. However, recent decades have seen successful public health measures to reduce this exposure. This study aimed to investigate the changing trends of male PUC in Taiwan compared to the United States of America (USA).
Materials and Methods
We conducted a retrospective analysis of data on male PUC patients at National Cheng Kung University Hospital (NCKUH), the only medical center near the black foot disease endemic area between 1975 to 2020. We also identified male PUC patients within Surveillance, Epidemiology and End Results (SEER) database to evaluate trends of PUC in the USA. To investigate potential trends over time, we categorized male PUC patients into two groups based on their diagnosis year. The year 2003 served as the dividing point.
Results
From 1975 to 2020, 24 and 641 male PUC patients were diagnosed in NCKUH and in SEER database respectively. Within NCKUH, a marked decrease in the prevalence of adenocarcinoma (43% to 0%) and a corresponding increase in transitional cell carcinoma (TCC, 21% to 90%) were observed. The predominant site of male PUC shifted from the bulbomembranous urethra (50%) to the penile urethra (50%). The SEER data, on the other hand, showed TCC remaining the most prevalent histological type (65% to 56%). However, a trend towards more advanced stages (31% to 38%, p= 0005) and increase of chemotherapy (13% to 29%, p < 0.001) was seen. Additionally, the SEER database exhibited a significant decrease in the incidence rate of male PUC cases (3 to 1.4 per 1,000,000, p < 0.001), particularly for TCC (2 to 0.8 per 1,000,000, p < 0.001), with an annual percentage change of -3.7 per 1,000,000.
Conclusions
Our analysis identified three significant trends in male PUC: 1. Over time, the histologic patterns of PUC at NCKUH evolved to resemble those observed in the USA, likely reflecting the success of public health measures in reducing chronic arsenic exposure in Taiwan. 2. The incidence rate of PUC in the USA decreased significantly, potentially linked to the declining prevalence of Human papillomavirus infection in the United States, a risk factor for PUC. Additionally, bladder cancer exhibits similar temporal trends, suggesting a possible shared carcinogenic pathway between these malignancies. 3. There has been an increase in the proportion of advanced-stage diagnoses, which may be attributed to stage migration as advanced diagnostic tools like computed tomography allowed more sensitive detection.
Keywords
Primary urethral cancer, Chronic arsenic exposure, Incidence rate, Time trend, Histology, Stage migration
Figure 1
https://storage.unitedwebnetwork.com/files/1237/9b60c96b75715e4ed281e3edfce71d7d.pdf
Figure 1 Caption
Table 1. Change in incidence of male primary urethral cancer in NCKUH
Figure 2
https://storage.unitedwebnetwork.com/files/1237/458d7378b6813b3a69b6cfcfcba2f76d.pdf
Figure 2 Caption
Table 2. Change in incidence of male primary urethral cancer in SEER database
Figure 3
https://storage.unitedwebnetwork.com/files/1237/c547f253b90658b81e8dc4f0de702398.pdf
Figure 3 Caption
Table 3.Trends in incidence of male primary urethral cancer per 100,000 persons during 1975 to 2015 in SEER database
Figure 4
https://storage.unitedwebnetwork.com/files/1237/4e96a6114a4b7efe4e33fba1c8ad289b.pdf
Figure 4 Caption
Age-standardized incidence rates of male primary urethral cancer per 100,000 persons in the United States from 1975 to 2020 according to histological subtypes and pathological stages at diagnosis.
Figure 5
Figure 5 Caption
Character Count
1815
Vimeo Link
Presentation Details
Session
Date
Time
Presentation Order